Design and Synthesis of EZH2-Based PROTACs to Degrade the PRC2 Complex for Targeting the Noncatalytic Activity of EZH2
Zhihao Liu(Sichuan University), Luoting Yu(State Key Laboratory of Biotherapy), Ningyu Wang(Southwest Jiaotong University), Rong Hu(China Pharmaceutical University), Xingping Su(Sichuan University), Qiangsheng Zhang(Sichuan University), Wei Wei(State Key Laboratory of Biotherapy), Qiwei Wang(Sichuan University), Yongxia Zhu(University of Electronic Science and Technology of China), Hualong He(Sichuan University), Xi Hu(Sichuan University), Tinghong Ye(State Key Laboratory of Biotherapy), Shuyan Zhou(Sichuan University), Xiuli Wu(Sichuan University)
Cited by 116
Related Papers
Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization
|Cancer Cell|2024|185
The Anthelmintic Drug Niclosamide Induces Apoptosis, Impairs Metastasis and Reduces Immunosuppressive Cells in Breast Cancer Model
|PLoS ONE|2014|131
Language Models of Code are Few-Shot Commonsense Learners
|Unknown|2022|106
PAL: Program-aided Language Models
|arXiv (Cornell University)|2022|104